Furthermore, cisplatin-resistant ovarian cancer tissues and cells were reported to have increased FOXM1 [232] and FOXM1 was an independent indicator of shorter time to progression in platinum-resistant EOC [222]. Here, FOXM1 is linked to ovarian carcinoma.